EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids

María-Cristina González-Montero iD, Julia Andrés-Rodríguez iD, Miguel Criado iD, Sonia Andrés iD, Giulio Galli iD, Celia Fernández-Rubio iD, Yolanda Pérez-Pertejo iD, Rosa M Reguera iD, Rafael Balaña-Fouce iD, Carlos García-Estrada iD

International Journal of Molecular Sciences · 18.12.2025 · 26 (24) · 12180

DOI: 10.3390/ijms262412180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.12.2025. Verfasst von María-Cristina González-Montero und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24007 León, Spain. Hauptthemen laut MEDLINE: Organoids, Liver, High-Throughput Screening Assays, Leishmania donovani. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades (MICIU)/AEI/10.13039/501100011033, "FED-ER, Una manera de hacer Europa", PRIMA Programme: European Union (NextGenerationEU) and Ministerio de Ciencia, In-novación y Universidades, MICIU/AEI/10.13039/501100011033 and by "ESF Investing in your future".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of new alternative models is essential to overcome the limitations of traditional two-dimensional (2D) cell cultures and animal models. Three-dimensional (3D) models, such as organoids, better mimic the structural and functional complexity of mammalian organs, thereby reducing the ethical and economic issues related to animal experimentation. These systems provide more physiologically relevant environments, improving the accuracy of disease modeling and drug response prediction. In this context, we have developed mouse hepatic organoids from livers of adult BALB/c mice and characterized them by microscopy and transcriptional analysis. This model was applied to a robust and reproducible high-throughput screening (HTS) platform for testing cytotoxicity at the preclinical stage of drug discovery. In addition, mouse hepatic organoids were co-cultured with amastigotes of Leishmania donovani parasites to establish a model of host–parasite interaction, which was characterized by RNA-seq linked to differential expression analysis and cytokine production by the hepatic organoids. The findings provided in this work establish mouse hepatic organoids as an alternative model for drug discovery and pathogenesis studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsLiverHigh-Throughput Screening AssaysLeishmania donovaniLeishmaniasisAnimalsMiceMice, Inbred BALB CDisease Models, AnimalHost-Parasite Interactions

Stichwörter der Autor:innen

Leishmaniaamastigotedrug discoveryhepatic tissuehigh-throughput screeningliverorganoidspathogenesis model

Autor:innen und Institutionen

  • Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24007 León, Spain.
  • Instituto de Ganadería de Montaña, CSIC-Universidad de León, Finca Marzanas s/n, Grulleros, 24346 León, Spain.
  • Instituto de Biomedicina (IBIOMED), Universidad de León, Campus de Vegazana s/n, 24007 León, Spain.

ORCID-Profile: María-Cristina González-Montero, Julia Andrés-Rodríguez, Miguel Criado, Sonia Andrés, Giulio Galli, Celia Fernández-Rubio, Yolanda Pérez-Pertejo, Rosa M Reguera, Rafael Balaña-Fouce, Carlos García-Estrada

Förderung

  • Ministerio de Ciencia, Innovación y Universidades (MICIU)/AEI/10.13039/501100011033, "FED-ER, Una manera de hacer Europa"
  • PRIMA Programme: European Union (NextGenerationEU) and Ministerio de Ciencia, In-novación y Universidades
  • MICIU/AEI/10.13039/501100011033 and by "ESF Investing in your future"

Zitieren

APA

González-Montero, M. C., Andrés-Rodríguez, J., Criado, M., Andrés, S., Galli, G., Fernández-Rubio, C., Pérez-Pertejo, Y., Reguera, R. M., Balaña-Fouce, R., & García-Estrada, C. (2025). Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids. International Journal of Molecular Sciences, 26(24), 12180. https://doi.org/10.3390/ijms262412180

Vancouver

González-Montero MC, Andrés-Rodríguez J, Criado M, Andrés S, Galli G, Fernández-Rubio C, et al. Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids. International Journal of Molecular Sciences. 2025;26(24):12180. doi:10.3390/ijms262412180

BibTeX
@article{GonzlezMontero2025,
  author = {González-Montero, María-Cristina and Andrés-Rodríguez, Julia and Criado, Miguel and Andrés, Sonia and Galli, Giulio and Fernández-Rubio, Celia and Pérez-Pertejo, Yolanda and Reguera, Rosa M and Balaña-Fouce, Rafael and García-Estrada, Carlos},
  title = {Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {24},
  pages = {12180},
  doi = {10.3390/ijms262412180}
}
Kostenlos starten →